Bringing embedded intelligence to the point of care to to deliver precision oncology evidence at the point of care, supporting evidence-informed treatment planning.
This is Precision Oncology 3.0.
A Oncology Clinical Outcome Engine enables powered by Multi-Modal data including DNA, RNA, radiology, pathology, EHR data, labs,ctDNA, toxicity and treatment history to deliver optimal therapy options at every step, with clear evidence and explainability.
We built a new operating system for Precision oncology - onethat captures every biological signal, unifies all data streams, and utilizes computational intelligence to drive the best treatment decision for everypatient.
As cancer evolves, our system evolves with it, helping oncologists deliver the
best-matched treatment plan, regardless of location or resource constraints.

Our clinical reasoning agents evaluate treatment options,weigh risks and benefits, align with established oncology guidelines, explain therapeutic rationale and automatically re-run analyses whenever new data arrives.
Thisproduces treatment-response insights, resistance signals, toxicity riskfactors, and outcome modeling – not as static reports but asintelligent, operational tools.
gSage CancerAI is our cancer intelligence and care platform– an integrated system built to provide precision oncology workflow in the clinic. It is the first platform designed to provide precision treatment matching at the point of care.
Get instant, reliable answers with evidence in seconds for quick reference.
Synthesize evidence for complex cases and surface clear rationale, with evidence.
A live snapshot of the latest patient information powered by gSage Date Flywheel.
Enables oncologists to simulate the patient’s tumor treatment with every new data update.
Autogenerate editable briefs with key points and references, with evidence.
Context-aware recommendations reflecting prior lines and biomarkers, with evidence.

gSage CancerAI learns, updates, and evolves its recommendations, just like the oncologists it supports. It builds a digital twin of each cancer patient to model potential outcomes. It inspires the care team to stay in continual learning mode to outthink and outpace cancer.
Our GPT-driven platform is embedded in clinical workflow and treatment protocols. We enable real-time decisions around first-line therapy, alternatives for emerging resistance, optimal switch points, next-line strategies after progression, and trial matching based on ongoing biology.
Synthesizes evidence from transcriptomics and patient context to prioritize options for clinician review.
Flags patterns that may be associated with emerging resistance, prompting consideration of follow-up testing.
Checks prior treatments, organ function, and contraindications, to support clinicians by identifying potential risks and outlining evidence-based alternative options.
Ranks therapies by guideline concordance, biomarker fit, and line-of-care timing.
Explainable option summaries with evidence-graded therapeutic option summaries.

gSage CancerAI chat explains your reports, labs, and scans in plain language.
Smart question builder creates personalized lists for your provider; save, print, or share securely.
A view that unites reports, biomarkers, treatments, and timelines kept current as new results arrive.
CBT-informed chat and mood tracking with simple exercises and weekly insights to help you cope.
Education and prompts aligned to your data, so you know what to ask, what to watch, and what’s next.
In a world where healthcare is rapidly evolving, Pioneering Health AI is at the forefront of innovation. GeneSilico™ cutting-edge solutions are designed to empower medical professionals, optimize patient care, and transform the way health data is utilized.
From predictive diagnostics to personalized treatment plans, we harness the power of artificial intelligence to make healthcare smarter, faster, and more efficient.
Together, we can reach more patients, improve survival, and transform outcomes. United
as one global team - with technology as our partner - we can advance, learn, and make a
meaningful difference for every person facing cancer.

Matching a patient's tumor multi-Omics bio-profile with most effective drugs for personalized treatment planning and progress tracking and RWE with Causal explainable AI.
Matching a patient's tumor multi-Omics bio-profile with most effective drugs for personalized treatment planning and progress tracking and RWE with Causal explainable AI.
Source, Generate and Share Case Summaries, Drug Matching Analysis, Tumor Board Briefs and Care Triage powered by Multi-Modal Data.
© 2026 GeneSilico. All rights Reserved.